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Oxygen-regulated expression of TGF-beta 3, a growth factor
involved in trophoblast differentiation
Abstract
The transforming growth factor-beta 3 (TGF-beta 3) is involved in oxygen-dependent differentiation
processes during placental development and pregnancy disorders. However, the importance of oxygen
partial pressure for the regulation of TGF-beta 3 expression is presently unclear. We and others
presented preliminary evidence that the hypoxia-inducible factor-1 (HIF-1) confers TGF-beta 3
transcription but it was unknown whether this occurred directly or indirectly. To analyze how HIF-1
regulates TGF-beta 3 gene transcription, we cloned and sequenced the mouse TGF-beta 3 promoter
region. Multiple putative HIF-1 binding sites (HBSs) were identified, many of which co-localized with
two G+C rich CpG islands 5' to the TGF-beta 3 transcription start site. A 6.8 kb fragment of the
TGF-beta 3 promoter induced reporter gene expression under hypoxic conditions or when treated with
an iron chelator known to stabilize and activate the HIF-1 alpha subunit. Deletion of a 2.4 kb fragment
upstream of the distal CpG island abolished inducibility of reporter gene expression. Two HBSs (HBS1
and HBS6) that bound the HIF-1 protein could be identified within this 2.4 kb fragment. These results
suggest that TGF-beta 3 gene expression is directly regulated by HIF-1.
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ABSTRACT 
The transforming growth factor-β3 (TGF-β3) is involved in oxygen-dependent differentiation 
processes during placental development and pregnancy disorders. However, the importance of 
oxgen partial pressure for the regulation of TGF-β3 expression is presently unclear. We and 
others presented preliminary evidence that the hypoxia-inducible factor-1 (HIF-1) confers 
TGF-β3 transcription but it was unknown whether this occurred directly or indirectly. To 
analyze how HIF-1 regulates TGF-β3 gene transcription, we cloned and sequenced the mouse 
TGF-β3 promoter region. Multiple putative HIF-1 binding sites (HBSs) were identified, many 
of which co-localized with two G+C rich CpG islands 5' to the TGF-β3 transcription start site. 
A 6.8 kb fragment of the TGF-β3 promoter induced reporter gene expression under hypoxic 
conditions or when treated with an iron chelator known to stabilize and activate the HIF-1α 
subunit. Deletion of a 2.4 kb fragment upstream of the distal CpG island abolished inducibility 
of reporter gene expression. Two HBSs (HBS1 and HBS6) that bound the HIF-1 protein could 
be identified within this 2.4 kb fragment. These results suggest that TGF-β3 gene expression is 
directly regulated by HIF-1. 
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INTRODUCTION 
Changes in oxygen partial pressure trigger several differentiation processes, including 
erythropoiesis, vasculogenesis/angiogenesis, thrombocytopoiesis, osteochondrogenesis and 
adipogenesis (Jelkmann, 1992; Risau, 1997; Mostafa et al., 2000; Lennon et al., 2001; Yun et 
al., 2002). Such differentiation processes are often mediated by oxygen-regulated expression of 
hormones or growth factors, including erythropoietin (Jelkmann, 1992) and vascular 
endothelial growth factor (VEGF) (Risau, 1997). Tissue oxygen partial pressure also 
determines placental trophoblast cell fate, thereby regulating placental growth and cellular 
architecture during placentation (Genbacev et al., 1997). Hypoxia-inducible TGF-β3 has been 
reported to maintain extravillous trophoblast proliferation by preventing first trimester 
trophoblast differentiation toward an invasive phenotype (Caniggia et al., 1999). Upon blood 
supply and oxygenation, TGF-β3 expression is downregulated and trophoblasts differentiate 
towards an invasive phenotype necessary for adequate remodelling of the uteroplacental 
circulation. Prolonged hypoxia-driven overexpression of TGF-β3 might interfere with this 
process, leading to placental structural aberrations as observed in the severe, hypoxia-
associated pregnancy disorder pre-eclampsia. Indeed, pathologically hypoxia-induced TGF-β3 
expression appears to be at least in part responsible for shallow trophoblast invasion, an excess 
of proliferative trophoblasts and a relatively immature trophoblast phenotype, whereas 
inhibiton of TGF-β3 restores the invasive properties of extravillous trophoblasts (Caniggia et 
al., 1999). 
 Many of the hypoxic adaptation processes in the body are based on transcriptional 
regulation by the hypoxia-inducible factors (HIF-1 and HIF-2) (Wenger, 2002). HIFs are 
heterodimers composed of a HIF α subunit and arylhydrocarbon receptor nuclear translocator 
(ARNT) (Wang et al., 1995). HIF-1α is an oxygen-labile protein that is very rapidly stabilized 
under hypoxic conditions (Jewell et al., 2001). Under normoxic conditions, HIF α subunits are 
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modified by oxygen- and iron-dependent prolyl and asparaginyl hydroxylation, leading to their 
functional inactivation and instability (Bruick and McKnight, 2001; Epstein et al., 2001; Ivan 
et al., 2001; Jaakkola et al., 2001; Hewitson et al., 2002; Lando et al., 2002a; Lando et al., 
2002b). Hydroxylated prolines are recognized by the von Hippel-Lindau (pVHL) tumor 
suppressor protein that mediates polyubiquitination and proteasomal degradation. Upon 
stabilization under hypoxic conditions, HIF-1 binds to HIF DNA-binding sites (HBSs) located 
in hypoxia-response elements (HREs) associated with oxygen-regulated genes such as 
erythropoietin and VEGF. HIF-1 thus represents a master regulator of at least two tissue 
differentiation processes, erythropoiesis and vasculogenesis/angiogenesis (Wenger, 2002).  
 Mice containing two disrupted alleles coding for pVHL (Gnarra et al., 1997) or for the 
common HIF subunit ARNT (Adelman et al., 2000), but not for either the HIF-1α (Iyer et al., 
1998) or the HIF-2α (Tian et al., 1998) subunit alone, die due to a failure in placental 
development. These data might suggest that HIF is essential for proper placental differentiation 
in the mouse and that the two α subunits apparantly are functionally redundant for this process. 
However, a HIF-1α/HIF-2α double knock-out mouse model will be required to draw more 
definitive conclusions about the role of HIFs in placental development. The mouse is an 
appropriate animal model to study the role of HIF-1 in TGF-β3 regulation since mouse 
trophoblast giant cells and spongiotrophoblasts are considered to be analogous to the human 
invasive and proliferative pool of extravillous trophoblasts, respectively (Cross, 2000; Rossant 
and Cross, 2001; Georgiades et al., 2002). In ARNT knock-out mice, an increase in trophoblast 
giant cells and a decrease in spongiotrophoblasts can be observed (Adelman et al., 2000), 
suggesting that the lack of HIF might lead to disinhibition of trophoblast differentiation 
towards an invasive phenotype, similar to oxygenation during physiological placenta 
development in wild-type mice. 
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 Recently, evidence has been provided that HIF-1 also appears to regulate TGF-β3 
transcription. We previously observed that expression of TGF-β3 parallels that of HIF-1α in 
sheep fetal skin at gestation day 100 and in embryonic fibroblasts cultured in vitro (Scheid et 
al., 2002). Caniggia and colleagues reported that TGF-β3 overlaps with HIF-1α expression 
during placental development (Caniggia et al., 2000). HIF-1α antisense oligonucleotides 
inhibited TGF-β3 expression in hypoxic human villous explants and promoted trophoblast 
differentiation (Caniggia et al., 2000). Consistent with these data, ARNT knock-out mice fail to 
develop a normal placenta and TGF-β3 expression is downregulated in the absence of ARNT 
(Adelman et al., 2000). In contrast to the results reported by Caniggia and co-workers, Simpson 
and colleagues did not observe striking temporal changes in TGF-β3 expression during human 
placentation (Simpson et al., 2002). The reason for this discrepancy is currently unclear and 
may reflect the shortlivety of hypoxia-inducible factors upon reoxygenation and/or the 
complexity of oxygen-regulated TGF-β3 expression. In an attempt to elucidate this controversy 
from the molecular biological viewpoint, we started to analyze the transcriptional mechanisms 
of oxygen-regulated mouse TGF-β3 expression. Although there is ample evidence that TGF-β3 
is a HIF-1 target gene, it is unknown whether TGF-β3 transcription is regulated by HIF-1 
directly or indirectly since functional data on TGF-β3 promoter regulation by HIF-1 were not 
available so far. Therefore, we cloned and characterized the mouse TGF-β3 5' flanking region 
and analyzed the role of HIF-1 in oxygen-regulated TGF-β3 expression.  
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MATERIALS AND METHODS 
Genomic cloning and sequencing of the mouse TGF-β3 5´-flanking region 
A mouse genomic λ phage library derived from the 129Sv(ev) embryonic stem cell line AB-1 
was screened as described before (Wenger et al., 1998c), using a radioactively labelled 490 bp 
fragment of the human TGF-β3 cDNA (ten Dijke et al., 1988) 5' region (kind gift of U. 
Malipiero and A. Fontana, Zürich, Switzerland). A 18 kb XhoI fragment derived from the 
phage clone λT2 was subcloned into pBluescript (Stratagene) resulting in the plasmid pT2X. 
The TGF-β3 5'-flanking region was sequenced on both strands using automated sequencing 
procedures according to the instructions provided by the manufacturer (Applied Biosystems). 
Identification of CpG islands was performed using the program cpgplot available at 
www.ebi.ac.uk/emboss. The genomic nucleotide sequence of the mouse TGF-β3 5' flanking 
region has been deposited in the EMBL/GenBank/DDBJ databases (accession number 
AJ414642). 
 
Cell culture and hypoxic induction 
The first trimester trophoblast-derived and SV40 large T antigen-immortalized cell line HTR-
8/SVneo (Graham et al., 1993) was a kind gift of C. H. Graham (Ontario, Canada). Mouse 
embryonic fibroblasts (MEFs) were derived from HIF-1α wild type (MEF-HIF+/+) and knock-
out (MEF-HIF-/-) embryos and immortalized/transformed by SV40 large T antigen and 
activated ras oncogene (kindly provided by R. S. Johnson, San Diego, USA) (Ryan et al., 
2000). The HT1080 fibrosarcoma cell line and the human hepatoma cell line HepG2 were 
obtained from American Type Culture Collection (ATCC numbers CCL-121 and HB-8065, 
respectively). HTR-8/SVneo cells were cultured in RPMI 1640 and all other cell lines in high-
glucose DMEM (Life Technologies, Gaithersburg, MD) supplemented with 10% heat-
inactivated FCS (Roche Molecular Biochemicals, Mannheim, Germany), 100 U/ml penicillin, 
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100 µg/ml streptomycin, 1x non-essential amino acids, 1 mM Na-pyruvate (all purchased from 
Life Technologies) at 37°C. Environmental air (20.7% O2) was humidified and supplemented 
with 5% CO2, resulting in an oxygen partial pressure within the incubator (Forma Scientific, 
Illkirch, France) or the hypoxia workstation (InVivO2-400, Ruskinn Technology, Leeds, UK) 
of 140 mmHg (normoxia, approx. 20% O2 vol/vol) or 7 mmHg (hypoxia, 1% O2 vol/vol). 
 
RNA blot analysis 
Total RNA was isolated from HTR-8/SVneo, MEF-HIF+/+ and MEF-HIF-/- cells using the 
Trizol method (Life Technologies). RNA was analyzed by Northern blotting using cDNA 
probes encoding TGF-β3, VEGF, ribosomal protein L28 and 28S rRNA as described 
previously (Rolfs et al., 1997). The signals were recorded and quantified using a 
PhosphorImager (Molecular Dynamics, Paul Bucher, Basel, Switzerland). 
 
Plasmid constructs and reporter gene assays 
pGL3BX3 was constructed by insertion of a 7 kb XhoΙ-BamHΙ fragment of the TGF-β3 5' 
flanking region into the SmaΙ site upstream of the luciferase reporter gene in the pGL3Basic 
vector (Promega). Reporter gene constructs pGL3BS2, pGL3Bg7 and pGL3K5KK19 were 
obtained by partial deletions of the pGL3BX3 plasmid. pGL3PCR1.8 was constructed by PCR 
amplification of the TGF-β3 minimal promoter fragment (-158 bp to 872 bp) and insertion into 
the pGL3Basic vector. Luciferase reporter gene constructs containing the heterologous SV40 
promoter were obtained by inserting the DNA sequences of interest into the multiple cloning 
site 5' to the SV40 promoter of the pGL3Promoter vector (Promega). pGL3promHBS1 and 
pGL3promHBS6 were constructed by inserting concatamerized oligonucleotides HBS1 and 
HBS6 (see below) upstream of the SV40 promoter. Copy number and orientation were 
determined by DNA sequencing using the RVprimer4 (Promega). The positive control 
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construct containing three concatamerized HBSs derived from the erythropoietin 3' enhancer 
has been described previously (Kvietikova et al., 1995).  
 For transient transfections 3.6 x 106 cells in 350 µl medium without FCS were mixed 
with 50 µg DNA in 50 µl 10 mM Tris/Cl (pH 7.4), 1 mM EDTA and electroporated at 250 V 
and 960 µF (GenePulser, Bio-Rad Laboratories). Luciferase reporter genes were co-
electroporated into cells together with the renilla reference vector pRL-SV40 (Promega). The 
cells were split and incubated for 38 hours under normoxic (20% O2) or hypoxic (1% O2) 
conditions with or without 100 µM deferoxamine mesylate (DFX, Sigma). After stimulation, 
transiently transfected cells were lysed in passive lysis buffer (Promega) and luciferase and 
renilla activities were determined according to the manufacturer's instructions (Promega) using 
a Lumat LB9501 luminometer (EG&G Berthold, Bad Wildbad, Germany). Differences in the 
transfection efficiency and extract preparation were corrected by normalization to the 
corresponding renilla activities. The results were displayed as fold induction of the activity of 
each reporter gene construct under normoxic conditions. 
 
Nuclear extract preparation 
Nuclear extracts were prepared as described previously (Kvietikova et al., 1995). Briefly, 
1x108 cells were washed twice with ice-cold phosphate-buffered saline and once with buffer A 
(10 mM Tris-HCl pH 7.8, 1.5 mM MgCl2, 10 mM KCl). After incubation on ice for 10 min, 
the cells were lysed by 10 strokes of a Dounce homogenizer, the nuclei were pelleted and 
resuspended in buffer C (420 mM KCl, 20 mM Tris-HCl pH 7.8, 1.5 mM MgCl2, 20% 
glycerol) and incubated at 4°C for 30 min with gentle agitation. Immediately before use, 
buffers A and C were supplemented with 0.5 mM dithiothreitol, 0.4 mM phenylmethylsulfonyl 
fluoride, 2 µg/ml each of leupeptin, pepstatin and aprotinin, and 1 mM Na3VO 4 (all purchased 
from Sigma). The nuclear extract was centrifuged and the supernatant was dialyzed twice 
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against buffer D (20 mM Tris-HCl pH 7.8, 100 mM KCl, 0.2 mM EDTA, 20% glycerol). 
Protein concentrations were determined using the Bradford protein assay (Bio-Rad) with 
bovine serum albumin as standard. 
 
Electrophoretic Mobility Shift Assay (EMSA) 
The following oligonucleotides were used as EMSA probes: HBS1, 5'-
TCAGGACACGTGGAGCTTAA-3'; HBS2, 5'-TAAAAGTCCACGACTTCCTG-3'; HBS3, 
5'-TCTTATGGCGTGGCAGAGAA-3'; HBS4, 5'-CTGAGGCACACGAGTGGGTG-3'; 
HBS5, 5'-TGAATGAACACGGTTCATCT-3'; HBS6, 5'-CCAAGGCCCACGTTCCGATC-3'; 
HBS7, 5'-ACACTTTCCACGAATTCCCC-3'. The oligonucleotides EPO and mtEPOHBS 
have been described previously (Kvietikova et al., 1995). Sense strands of purified 
oligonucleotides (Microsynth) were 5' end-labeled with (γ-32P)ATP (Hartmann) using T4-
polynucleotide kinase (Fermentas). Unincorporated nucleotides were removed by gel filtration 
over Bio-Gel P60 (fine) columns (Bio-Rad). Labeled sense strands were annealed to a 2-fold 
molar excess of unlabeled antisense strands. DNA-protein binding reactions were carried out at 
4°C overnight in a total volume of 20 µl containing 5 µg of nuclear extract, 0.2 µg of sonicated 
denatured calf thymus DNA (Sigma) and 1x104 cpm of oligonucleotide probe in 10 mM Tris-
HCl pH 7.5, 50 mM KCl, 50 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5 mM dithiothreitol and 
5% glycerol. Electrophoresis was performed with 4% non-denaturing polyacrylamide gels at 
200 V in TBE buffer (89 mM Tris, 89 mM boric acid, 5 mM EDTA) at 4°C. For supershift 
analysis, 1 µl of monoclonal mouse anti-HIF-1α antibody mgc3 (Camenisch et al., 1999) was 
added to the completed EMSA reaction mixture and incubated overnight at 4°C prior to 
loading. 
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RESULTS 
Structure of the mouse TGF-β3 promoter region 
To analyze the transcriptional regulation of the TGF-β3 gene, we cloned and sequenced the 
mouse 5' flanking region from a λ phage library (Fig. 1A). Sequence comparison with the 
human and chicken TGF-β3 5' flanking regions revealed a conserved proximal promoter region 
containing the transcription start site, a TATA box, a TCCC motif, an AP-2 site and a cAMP-
response element (CRE) important for basal expression, tissue-specific expression and 
forskolin induction (Lafyatis et al., 1990; Lafyatis et al., 1991; Jakowlew et al., 1992). As 
reported earlier for the chicken TGF-β3 promoter (Jakowlew et al., 1992), the mouse TGF-β3 
promoter showed no further homology to the distal promoter region of the human TGF-β3 
gene. In analogy to the human and chicken TGF-β3 5' flanking regions (Lafyatis et al., 1990; 
Jakowlew et al., 1992), a number of putative SP-1 consensus elements were identified (data not 
shown). Of note, an unusually high number of the conserved HBS core element CGTG 
(Camenisch et al., 2001) could be detected in the mouse TGF-β3 5' flanking region (Fig. 1B). 
 Both SP-1 sites and HBSs contain CpG dinucleotides in their consensus recognition 
sites. Because the CpG frequency is suppressed outside of CpG islands (Adams, 1990; Tate 
and Bird, 1993; Antequera and Bird, 1999; Attwood et al., 2002), SP-1 sites and HBSs are 
frequently associated with CpG islands. We therefore analyzed the presence of putative CpG 
islands in the TGF-β3 5' flanking region (Fig. 1C-E). A CpG island was defined as a stretch of 
at least 200 bp containing more than 60% G+C (Fig. 1C) and an observed/expected CpG 
content of more than 0.6 (Fig. 1D). Under these criteria, two CpG islands could be identified: a 
proximal CpG island associated with the known transcription start site as reported before (Burt 
et al., 1991), and a novel distal CpG island located 3.5 kb upstream of the mapped transcription 
start site (Fig. 1E).  
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HIF-1 is required for basal TGF-β3 mRNA expression 
HIF-1 and TGF-β3 have been reported to be induced in villous explants under hypoxic 
conditions (Caniggia et al., 2000; Rajakumar and Conrad, 2000) as well as by iron chelation 
(De Marco and Caniggia, 2002). We thus analyzed TGF-β3 mRNA expression in a first 
trimester trophoblast-derived cell line (HTR-8/SVneo) cultured under normoxic or hypoxic 
conditions, or treated with the hypoxia-mimicking iron chelator DFX. Previous 
immunoblotting experiments confirmed hypoxic HIF-1α induction in these cells, whereas HIF-
2α could not be detected (data not shown). Northern blotting revealed low TGF-β3 and VEGF 
mRNA levels in this cell line and hypoxia moderately stimulated expression after 21 hours 
(Fig. 2A). However, the iron chelator DFX, well known to stabilize and functionally activate 
HIF-1α (Wang and Semenza, 1993; Wanner et al., 2000), clearly induced TGF-β3 and the 
prototypical HIF-1-regulated VEGF, but not the L28 control mRNA, after 21 hours of 
incubation. 
 We next analyzed mouse embryonic fibroblasts (MEFs) derived from mice that were 
either wild type (MEF-HIF+/+) or mutant (MEF-HIF-/-) for the HIF-1α gene (Ryan et al., 
2000). Both, basal as well as hypoxically induced TGF-β3 and VEGF mRNA levels were 
drastically reduced in MEF-HIF-/- compared with MEF-HIF+/+ cells (Fig. 2B). Residual 
hypoxic VEGF mRNA induction in MEF-HIF-/- cells can be attributed to the well known 
increase in mRNA stability. Although the same amounts of total RNA were loaded in each 
lane, as indicated by the 28S rRNA signal, L28 mRNA was apparently increased following 24 
hrs of hypoxia. Whether this is due to specific hypoxic induction or a shift in the mRNA to 
rRNA ratio is currently unknown. However, this notion does not affect the conclusion that 
expression of both TGF-β3 and VEGF mRNA clearly depends on HIF-1α. 
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Complex regulation of the mouse TGF-β3 promoter 
In order to analyze TGF-β3 promoter activity, 6.8 kb of the TGF-β3 5' flanking region were 
used to drive expression of a heterologous luciferase reporter gene in HT1080 fibrosarcoma 
cells. This cell line has extensively been used to study the human TGF-β3 promoter activity 
(Lafyatis et al., 1990). Following transient transfection of HT1080 cells, the TGF-β3 promoter 
induced luciferase expression 4.2-fold under hypoxic conditions and 11-fold when treated with 
100 µM DFX (Fig. 3A), consistent with the stronger mRNA response to DFX than to hypoxia 
in the first trimester trophoblast cell line (Fig. 2A). Similar induction levels were obtained with 
a positive control construct containing the heterologous SV40 promoter and 3 concatamerized 
HBSs derived from the erythropoietin 3' enhancer. We then attempted to identify promoter 
regions critically involved in oxygen- and iron-regulated TGF-β3 promoter activity. 
Interestingly, promoter fragments ranging up to -3794 bp, -719 bp and -160 bp upstream of the 
transcription start showed equal luciferase expression under the different conditions (Fig. 3A). 
Thus, deletion of the distal promoter region associated with the second distal CpG island 
completely abolished hypoxic and DFX-dependent inducibility.  
 To test whether the distal 5' region behaves like a hypoxia-inducible enhancer element, 
several fragments thereof were ligated to a heterologous SV40 promoter. Although the same 
regions were included whose deletion previously prevented inducibility, none of these 
fragments was able to confer hypoxic or DFX inducibility to the SV40 promoter (Fig. 3B). The 
same result was obtained when a distal 2.4 kb fragment was linked to 1.2 kb of the proximal 
endogenous TGF-β3 promoter region (Fig. 3A, construct pGL3K5KK19). In summary, these 
results suggest that a complex interplay between proximal promoter regions and distal 
enhancer regions confers TGF-β3 gene regulation under hypoxic or iron depleted conditions. 
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Identification of functional HIF-1 DNA-binding sites in the distal mouse TGF-β3 
promoter region 
To investigate whether HIF-1 interacts with the TGF-β3 5' regulatory elements, the sequence 
shown in Fig. 1 was screened for putative HBS containing the core consensus element CGTG 
(Camenisch et al., 2001). A total of seven putative HBSs (HBS1 to HBS7; Fig. 1) could be 
identified in the distal promoter region responsible for hypoxia- and DFX-inducible TGF-β3 
transcription. Oligonucleotides encompassing these putative HBSs were synthesized and 
incubated with nuclear extracts derived from hypoxic cells. DNA-protein interaction was 
studied by EMSA and the presence of HIF-1 was confirmed by the intense shifts obtained with 
an erythropoietin 3' enhancer-derived HBS ("Epo" in Fig. 4). Supershifts obtained after the 
addition of a monoclonal anti-HIF-1α antibody (Camenisch et al., 1999) confirmed the identity 
of the EMSA bands. Of the seven putative HBSs, only HBS1 and HBS6 detectably bound to 
HIF-1 though the signal intensity was clearly below that of the Epo oligonucleotide probe. 
Similar nonspecific signal intensities demonstrate that the specific labelling and the amount of 
nuclear protein extract was identical in the HBS1, HBS6 and Epo EMSAs (Fig. 4). 
 Having established that HBS1 and HBS6 constitute functional HIF-1 DNA-binding 
sites, we analyzed whether concatamerized HBS1 and HBS6 oligonucleotides could confer 
hypoxia and DFX inducibility to the heterologous SV40 promoter, like previously shown for 
the erythropoietin and transferrin HBSs (Kvietikova et al., 1995; Rolfs et al., 1997; Wanner et 
al., 2000). However, in contrast to the 6.8 kb TGF-β3 promoter region and unlike the 
concatamerized erythropoietin-derived HBSs, concatamerized TGF-β3-derived HBS1 and 
HBS6 were not able to activate reporter gene expression by hypoxia or DFX (Fig. 3B). These 
results are consistent with the finding that the isolated TGF-β3 5' region, from which the two 
HBSs originated, is not functional in the context of both homologous and heterologous 
promoters, but rather requires the presence of the intervening sequence. 
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DISCUSSION 
The TGF-β3 gene is expressed in a highly tissue-specific manner during various differentiation 
processes. Oxygen modulates TGF-β3 gene expression and we and others presented 
preliminary evidence that TGF-β3 might be a HIF-1 target gene (Caniggia et al., 2000; Scheid 
et al., 2002). Cells deficient for HIF-1α showed both decreased basal and hypoxic TGF-β3 
levels. These data are consistent with results obtained in murine trophoblast stem cells deficient 
for ARNT, the mandatory heterodimerization partner of HIF-1α (Adelman et al., 2000). The 
phenomenon of decreased normoxic HIF target gene (including TGF-β3) expression in MEF-
HIF-/- compared with MEF-HIF+/+ cells has previously been observed by many other groups 
working with cells deficient for one of the HIF components (Iyer et al., 1998; Ryan et al., 
1998; Wenger et al., 1998a; Scheid et al., 2002). The most obvious explanation might be that 
under normoxic conditions there is already sufficient functional HIF protein present to activate 
target gene expression but which is not sufficient enough to allow the detection using common 
methods such as Western blot analysis.  
 As a first step towards the molecular elucidation of how tissue-specific and conditional 
factors result in TGF-β3 gene activation, we cloned and characterized the 5' flanking region of 
the mouse TGF-β3 gene. The TGF-β3 promoter is associated with a CpG island as it is often 
found in gene regulatory regions, in particular in hypoxia-inducible promoters containing 
HBSs such as the genes encoding glycolytic enzymes (Wenger, 2002). However, this proximal 
promoter region could not confer hypoxia and iron depletion inducibility to a reporter gene, 
suggesting that the multiple putative HBSs found within this region are not part of functional 
HREs.  
 Following the cloning of TGF-β3 gene upstream regions, we identified two HBSs in a 
distal 5' flanking region which are necessary but not sufficient for oxygen- and iron-regulated 
TGF-β3 promoter function. This upstream region is associated with a second G+C rich region 
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containing a CpG island. We showed previously that CpG methylation inhibits HIF-1 DNA-
binding and transactivation function (Wenger et al., 1998b). Because CpG dinucleotides are 
usually C-methylated in the mammalian genome if located outside of methylation-free CpG 
islands (Adams, 1990; Tate and Bird, 1993; Antequera and Bird, 1999; Attwood et al., 2002), 
the distal CpG island might be required to prevent methylation of the two functional HBSs. On 
the other hand, the proximal CpG island contains the conserved functionally important 
elements for cAMP responsiveness and transcription initiation (Lafyatis et al., 1990). Thus it is 
tempting to speculate that these two regions contribute in concert to TGF-β3 transcription and 
each region is associated with a CpG island to keep the chromatin in an "open" conformation. 
 The two identified HBSs consisted of the extended core sequence ACGTG, 
corresponding to the most often found sequence for a HBS (Camenisch et al., 2001). However, 
the adjacent 5' and 3' nucleotides were less often found in the HBSs identified so far in other 
genes, providing an explanation for the weaker HIF-1 DNA-binding to these TGF-β3-derived 
HBSs compared with the prototypical erythropoietin-derived HBS. Attenuation of HIF-1 
DNA-binding is consistent with the observed relatively mild hypoxic induction in the cell lines 
used, suggesting that TGF-β3 gene transcription is regulated by a complex interplay between 
hypoxia-inducible distal elements and tissue-specific as well as intracellular signalling-
dependent proximal elements. In addition, lower oxygen concentrations, as simulated by DFX, 
might lead to higher induction levels. Indeed, DFX (Figs. 2 and 3) and 0.1% O2 (data not 
shown) led to stronger induction levels of TGF-β3 and VEGF than 1% O2 in HTR-8/SVneo 
cells. This effect might be related to the specific repertoire of HIF prolyl hydroxylase family 
members expressed in this particular cell line, which are probably more completely blocked by 
iron chelation than by 1% O2. 
 Regulation of the TGF-β3 gene by HIF-1 provides a novel possibility to interfere with 
TGF-β3 expression. Small molecule inhibitors of the prolyl hydroxylases have been shown to 
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stabilize HIF-1α (Epstein et al., 2001; Willam et al., 2002; Linden et al., 2003). Pharmacologic 
HIF-1 induction might be applied under circumstances where increased VEGF and TGF-β3 
expression is desirable. One example might be the treatment of skin wounds, profiting from the 
potential pro-angiogenic (VEGF-mediated) and anti-scarring (TGF-β3-mediated) effects. In 
pre-eclamptic placentae, overexpression and impaired oxygen-dependent reduction of TGF-β3 
and HIFα has been reported (Caniggia et al., 1999; Rajakumar et al., 2001; Rajakumar et al., 
2003). Therefore, HIFα inhibitors might be desirable as they should downregulate TGF-β3 
expression during the development of pre-eclampsia. We and others recently identified small 
molecule inhibitors that interfere with HSP90-dependent HIFα synthesis and activation 
(Katschinski et al., 2002; Rapisarda et al., 2002). Of note, the complete lack of HSP90β in 
knock-out mice prevents the development of a placental labyrinth (Voss et al., 2000), 
demonstrating the power of this mechanism and suggesting a probable application of these 
small molecule inhibitors in the treatment of pre-eclampsia.  
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FIGURE LEGENDS 
 
Figure 1. The mouse TGF-β3 promoter region contains two CpG islands. (A) Map of the 
mouse TGF-β3 5' flanking region. Restriction sites and the transcription start site are indicated. 
(B) Putative HBSs conforming to the CGTG consensus HBS core element. (C) Plot of the 
%G+C content in a window of 100 bp shifted in steps of 1 bp. (D) Plot of the CpG content 
(observed/expected = CpG/{CxG/window length}) in a window of 100 bp shifted in steps of 1 
bp. (E) Predicted CpG islands. Threshold: CpG content >0.6; %G+C content >50%; length 
>200 bp. All figures are drawn to scale. 
 
Figure 2. HIF-1-dependent TGF-β3 mRNA expression. RNA blot analysis of TGF-β3 and 
VEGF mRNA expression in HTR-8/SVneo first trimester trophoblasts (A) and in HIF-1α wild 
type (+/+) and knock out (-/-) mouse embryonic fibroblasts (MEF) (B). The cells were cultured 
for 21 to 24 hours under normoxic or hypoxic conditions or treated with the iron chelator DFX 
(100 µM) as indicated. Ribosomal protein L28 mRNA and 28S rRNA served as control for 
loading and blotting efficiency. 
 
Figure 3. Transcriptional activity of the TGF-β3 5' flanking region. Relative luciferase reporter 
gene expression following transient transfection of HT1080 cells and exposure to hypoxia or 
DFX for 38 h. (A) Promoterless luciferase expression vectors containing 6.8 kb of the TGF-β3 
5' flanking region and deletions thereof. (B) SV40 promoter-driven luciferase expression 
vectors containing various fragments of the TGF-β3 5' flanking region or concatamerized 
HBSs shown to interact with HIF-1 in Fig. 4. The positive control consists of the SV40-
luciferase expression cassette linked to three concatamerized HBSs derived from the 
erythropoietin 3' enhancer (Kvietikova et al., 1995). The location of the putative HBSs is 
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indicated. A co-transfected renilla luciferase expression vector served as internal control for 
transfection efficiency and extract preparation. Relative values (means ± SD of n = 3 
independent experiments) are shown which were normalized to the untreated normoxic 
luciferase activities of each construct (arbitrarily defined as 1). 
 
Figure 4. Protein-DNA interaction of HIF-1 with HBSs derived from the distal TGF-β3 5' 
flanking region. EMSA of HIF-1 DNA-binding to oligonucleotide probes containing the 
putative HBS1 to HBS7 (see Figs. 1 and 3) or a HBS derived from the erythropoietin 3' 
enhancer (Epo). As a source of HIF-1, nuclear extracts of HepG2 cells were used which have 
been exposed to 4 hours of hypoxia (Katschinski et al., 2002). The identity of HIF-1 was 
confirmed by supershift analysis with an anti-HIF-1α monoclonal antibody. ATF-1/CREB 
denote the transcription factors constitutively binding to HBSs as identified previously 
(Kvietikova et al., 1995). 
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ABSTRACT 
The transforming growth factor-β3 (TGF-β3) is involved in oxygen-dependent differentiation 
processes during placental development and pregnancy disorders. However, the importance of 
oxgen partial pressure for the regulation of TGF-β3 expression is presently unclear. We and 
others presented preliminary evidence that the hypoxia-inducible factor-1 (HIF-1) confers 
TGF-β3 transcription but it was unknown whether this occurred directly or indirectly. To 
analyze how HIF-1 regulates TGF-β3 gene transcription, we cloned and sequenced the mouse 
TGF-β3 promoter region. Multiple putative HIF-1 binding sites (HBSs) were identified, many 
of which co-localized with two G+C rich CpG islands 5' to the TGF-β3 transcription start site. 
A 6.8 kb fragment of the TGF-β3 promoter induced reporter gene expression under hypoxic 
conditions or when treated with an iron chelator known to stabilize and activate the HIF-1α 
subunit. Deletion of a 2.4 kb fragment upstream of the distal CpG island abolished inducibility 
of reporter gene expression. Two HBSs (HBS1 and HBS6) that bound the HIF-1 protein could 
be identified within this 2.4 kb fragment. These results suggest that TGF-β3 gene expression is 
directly regulated by HIF-1. 
 
